Skip to content

A sensible approach in glaucoma care.

Glaucoma and Cataracts

Intervention for glaucoma during the cataract surgery patients already need just makes sense. Intervening with technology that doesn’t require an implant, has been shown to provide long-term IOP reduction, and is seamlessly adopted makes even more sense.

However, cataract and glaucoma are not always addressed simultaneously even though up to 20% of patients with cataracts also have glaucoma. Present MIGS have not succeeded in making combined cataract and glaucoma treatment a standard of care.

32 million

cataract procedures are performed worldwide each year1

up to 20%

of patients undergoing cataract surgery also have glaucoma / OHT2

Drop therapy is the mainstay of glaucoma treatment but can be a burden on patients and impact their quality of life. Lowering medication burden can have a positive effect on health-related quality of life.3
Ophthalmologist looking forward
Play Video

ELIOS™ Is the Next Generation of Glaucoma Technology

ELIOS uses high precision, non-thermal, laser ablation to create 10 microchannels in the trabecular meshwork to enhance physiological outflow into Schlemm’s canal whilst preserving angle anatomy.6

The first clinically-validated excimer laser MIGS7

ELIOS console and probe
IOP (>20%) for up to 8 years6
Up to 80% of patients are medication-free one year after their surgery8
ELIOS microchannels at 31 months post-op
Image courtesy of Dr. Antonio Moreno-Valladares
Long-term microchannel patency9
Ike-Ahmed-1
“The synergy of cataract surgery and MIGS is ideal… ELIOS provides a standardized, implant-free, and highly adoptable procedure that can be done in that patient population.”
Prof. Ike K. Ahmed
University of Toronto & Moran Eye Center
Karsten Klabe
“In my opinion, there is no learning curve at all. If [surgeons] have experience with trabecular bypass implants or ab-interno canaloplasty, [they] have the skills to perform ELIOS.”
Dr. Karsten Klabe
Breyer, Kaymak & Klabe
Philippe Denis
“Techniques [like ELIOS] that avoid having to create a bleb and all of its potential side effects — especially in patients with mild-to-moderate glaucoma — make it easier to get IOP under control with topical pharmacotherapy. This is a large and significant patient population.”
Prof. Phillipe Denis
Croix-Rousse University Hospital

Good for Patients Means Good for You

For patients with concomitant glaucoma and cataract, ELIOS is a procedure that:
  • Consolidates the two procedures into one10
  • May alleviate the burden of daily eye drops6
  • Can provide long-lasting IOP reduction6
  • Does not involve the use of an implant in the eye11
For doctors who care for glaucoma patients, ELIOS:
  • Is highly adoptable11
  • Avoids the use of an implant11
  • Offers flexibility as a combined or standalone procedure12
  • Can be conveniently integrated into standard OR routines12

Resources for Healthcare Professionals

Visit our resource library for additional materials, including resources in French, German, Italian, Portuguese, and Spanish.

View Resource Library
×

Site for Healthcare Professionals Only

You are about to access Elios Vision’s online platform for healthcare professionals outside of the United States. This platform is intended to provide general product information for education and illustration purposes. It is not intended to provide information to the general public or medical advice.

As product information, availability, indication, and trade names may vary from country to country, the content of this site may not be fully in-line with the approved or cleared product information in the country you are accessing from. Unless stated otherwise for specific product or event pages, the content on this site is based on the regulatory and legal principles applicable to the United Kingdom.

By closing this popup, I confirm that:

  • I understand that this platform is directed to Healthcare Professionals only and that I am a licensed Healthcare Professional.
  • I have read and agree to Elios Vision’s terms and conditions and privacy policy.